At Tolmar, we’re driven by science. It’s where our story starts and it continues to guide us in achieving our mission. We develop novel treatments and innovative solutions through our steadfast dedication to scientific and technology-based advancement.
Through our focus on the therapeutic areas of urology, oncology and dermatology, Tolmar is committed to advancing patient care around the world. We work to meet their current and future needs by researching, developing and delivering novel therapies. Our flagship product, ELIGARD® (leuprolide acetate for injectable suspension), is the only LHRH agonist marketed worldwide with the innovative ATRIGEL® Delivery System.
Tolmar’s state-of-the-art product development, clinical research, and manufacturing facilities in Northern Colorado are dedicated to the continuous discovery and development of medicines that advance patient care worldwide.